| Autor: |
Gruszczynska A; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Maiti A; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., Miller CA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Ramakrishnan SM; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Link DC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Uy GL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Petti AA; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri 63110., Hayes K; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., DiNardo CD; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., Ravandi F; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., Ley TJ; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Spencer DH; Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110., Gao F; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri 63110., Konopleva MY; Albert Einstein College of Medicine, Bronx, New York 10461., Welch JS; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110; A2 Biotherapeutics, Agoura Hills, California 91301 (work completed while at Washington University). jwelch@a2biotherapeutics.com. |
